Carboxylesterase 2 (CES2), the main carboxylesterase expressed in human intestine, is an increasingly important enzyme in anti-cancer combined therapies for the treatment of different pathologies like colon adenocarcinoma and malignant glioma. The production of human recombinant CES2, in human embryonic kidney cells (HEK-293T cells) using serum-free media, is herein described. CES2 secretion to the media was achieved by the simple addition of an in-frame C-terminal 10× histidine tag (CES2-10xHis) without the need of addition of extra N-terminal signalling sequences or the mutation or deletion of the C-terminal HTEL motif responsible for retaining the protein in the lumen of endoplasmic reticulum. This secretion allowed a fourfold increase in CES2 production. The characterization of human recombinant CES2 showed that this protein exists in other active and inactive forms than the described 60 kDa monomer.
| Authors: |
|
Joana Lamego, Bárbara Cunha, Cristina Peixoto, Marcos F. Sousa, Paula M. Alves, Ana L. Simplício, Ana S. Coroadinha |
| Journal: |
|
Applied Microbiology and Biotechnology
|
| Year: |
|
2012 |
| DOI: |
|
10.1007/s00253-012-3994-3 |
| Publication date: |
|
24-03-2012 |